Molecular and pathophysiological mechanisms in human obesity

人类肥胖的分子和病​​理生理机制

基本信息

  • 批准号:
    G0900554-E01/1
  • 负责人:
  • 金额:
    $ 315.4万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2009
  • 资助国家:
    英国
  • 起止时间:
    2009 至 无数据
  • 项目状态:
    已结题

项目摘要

Obesity is an important medical problem as it can lead to early death from diabetes, heart attacks and strokes and also causes considerable chronic ill health and a lowered quality of life. While it is clear that the reasons behind the recent increase in the frequency of obesity in most populations must lie in changes in factors such as the availability, cost and quality of food and the reduction in the need for physical activity it is also important to ask why, in the face of these environmental factors some people stay slim while others gain weight. We know from studies of twins and adopted children that genetics is a very important factor in determining the risk of becoming obese. Indeed in some children with very severe obesity from a young age we have found mutations in single genes that are sufficient in themselves to result in the child?s obesity. In one case we have been able to completely cure obesity by replacing the ?broken? gene product. We study a group of ~3500 severely obese children and so far have found a single gene mutation causing obesity in about 10% of these. New techniques for finding disease genes are now available and we want to use a range of novel approaches to try to find the causes of obesity in the rest of these children. We hope that by knowing the cause we will be able to better target treatment. As well as the severe mutations that result in morbid obesity in children there are other more recently discovered subtle genetic variants each of which are common and alter a person?s weight by a few pounds. Some of these variants are in genes that were not expected to have an effect on body weight. We also plan to better understand how those genes contribute to body weight and whether manipulating them by drugs, diet or exercise might provide new approaches to treating obesity.
肥胖是一个重要的医学问题,因为它会导致糖尿病、心脏病发作和中风的过早死亡,也会导致相当多的慢性疾病和生活质量下降。虽然很明显,最近大多数人群肥胖频率增加的原因必须在于食物的可用性,成本和质量以及体力活动需求减少等因素的变化,但同样重要的是要问为什么面对这些环境因素,有些人保持苗条,而另一些人则增加体重。我们从对双胞胎和收养儿童的研究中得知,遗传是决定肥胖风险的一个非常重要的因素。事实上,在一些儿童非常严重的肥胖,从一个年轻的年龄,我们已经发现突变的单基因是足以在自己的结果在孩子?s肥胖。在一种情况下,我们已经能够完全治愈肥胖取代?坏了?基因产物我们研究了一组约3500名严重肥胖儿童,到目前为止,发现其中约10%的儿童因单一基因突变而肥胖。寻找疾病基因的新技术现在已经出现,我们希望使用一系列新的方法来试图找到这些儿童肥胖的原因。我们希望通过了解原因,我们将能够更好地进行针对性治疗。除了导致儿童病态肥胖的严重突变外,最近还发现了其他微妙的遗传变异,每一种都很常见,并改变了一个人?He’他的体重减轻了几磅。这些变异中的一些基因预计不会对体重产生影响。我们还计划更好地了解这些基因是如何影响体重的,以及通过药物、饮食或运动来操纵它们是否可能为治疗肥胖提供新的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen O'Rahilly其他文献

Obesity therapy: altering the energy intake-and-expenditure balance sheet
肥胖治疗:改变能量摄入与支出的资产负债表
  • DOI:
    10.1038/nrd770
  • 发表时间:
    2002-04-01
  • 期刊:
  • 影响因子:
    101.800
  • 作者:
    Vivion E. F. Crowley;Giles S. H. Yeo;Stephen O'Rahilly
  • 通讯作者:
    Stephen O'Rahilly
Damaging missense variants in emIGF1R/em implicate a role for IGF-1 resistance in the etiology of type 2 diabetes
  • DOI:
    10.1016/j.xgen.2022.100208
  • 发表时间:
    2022-12-14
  • 期刊:
  • 影响因子:
    9.000
  • 作者:
    Eugene J. Gardner;Katherine A. Kentistou;Stasa Stankovic;Samuel Lockhart;Eleanor Wheeler;Felix R. Day;Nicola D. Kerrison;Nicholas J. Wareham;Claudia Langenberg;Stephen O'Rahilly;Ken K. Ong;John R.B. Perry
  • 通讯作者:
    John R.B. Perry
Partial leptin deficiency and human adiposity
瘦素部分缺乏与人类肥胖症
  • DOI:
    10.1038/35102112
  • 发表时间:
    2001-11-01
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    I. Sadaf Farooqi;Julia M. Keogh;Sri Kamath;Sarah Jones;William T. Gibson;Rebecca Trussell;Susan A. Jebb;Gregory Y. H. Lip;Stephen O'Rahilly
  • 通讯作者:
    Stephen O'Rahilly
Leptin therapy in lipodystrophy
瘦素治疗脂肪营养不良
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    8.2
  • 作者:
    David B. Savage;Stephen O'Rahilly
  • 通讯作者:
    Stephen O'Rahilly
Life without leptin
没有瘦素的生活
  • DOI:
    10.1038/32769
  • 发表时间:
    1998-03-26
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Stephen O'Rahilly
  • 通讯作者:
    Stephen O'Rahilly

Stephen O'Rahilly的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen O'Rahilly', 18)}}的其他基金

Establishment of a physiological culture system to improve translation in metabolic research
建立生理培养体系以提高代谢研究转化
  • 批准号:
    MC_PC_20047
  • 财政年份:
    2021
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Intramural
MRC Centre for Translational Research in Obesity and related Metabolic Diseases
MRC 肥胖及相关代谢疾病转化研究中心
  • 批准号:
    G0600717/1
  • 财政年份:
    2007
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Research Grant
Targeting therapy to molecular mechanism of disease in obesity and related metabolic disorders
肥胖及相关代谢紊乱疾病分子机制的靶向治疗
  • 批准号:
    G0502115/1
  • 财政年份:
    2006
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Research Grant

相似海外基金

Molecular and Cellular signaling mechanisms of TRPV4 in non-neuronal cells: a pathophysiological relevance for migraine pain.
非神经元细胞中 TRPV4 的分子和细胞信号传导机制:与偏头痛的病理生理学相关性。
  • 批准号:
    10371665
  • 财政年份:
    2021
  • 资助金额:
    $ 315.4万
  • 项目类别:
Molecular and Cellular signaling mechanisms of TRPV4 in non-neuronal cells: a pathophysiological relevance for migraine pain.
非神经元细胞中 TRPV4 的分子和细胞信号传导机制:与偏头痛的病理生理学相关性。
  • 批准号:
    10532165
  • 财政年份:
    2021
  • 资助金额:
    $ 315.4万
  • 项目类别:
Molecular mechanisms of a functional linkage between epigenome and mitochondria, and its pathophysiological association
表观基因组与线粒体功能联系的分子机制及其病理生理学关联
  • 批准号:
    15H04707
  • 财政年份:
    2015
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical, molecular and pathophysiological characterization of Pol III-related leukodystrophies
Pol III 相关脑白质营养不良的临床、分子和病理生理学特征
  • 批准号:
    267420
  • 财政年份:
    2012
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Operating Grants
Elucidation of molecular mechanisms of pathophysiological pain via nociceptive channels and establishment of pain-evaluating system
通过伤害感受通道阐明病理生理性疼痛的分子机制并建立疼痛评估体系
  • 批准号:
    22380160
  • 财政年份:
    2010
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of renal fibrosis: analysis of the pathophysiological role of Platelet Derived Growth Factor-C (PDGF-C) (P14)
肾纤维化的分子机制:血小板衍生生长因子-C(PDGF-C)的病理生理作用分析(P14)
  • 批准号:
    94967810
  • 财政年份:
    2009
  • 资助金额:
    $ 315.4万
  • 项目类别:
    CRC/Transregios
Analysis of molecular mechanisms by which heme oxygenase-carbon monoxide pathway regulates cellular functions under physiological and pathophysiological conditions using newly developed gene targeting mice.
使用新开发的基因靶向小鼠分析血红素加氧酶-一氧化碳途径在生理和病理生理条件下调节细胞功能的分子机制。
  • 批准号:
    14370063
  • 财政年份:
    2002
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on molecular and pathophysiological mechanisms in age related brain disease
年龄相关脑疾病的分子和病​​理生理机制研究
  • 批准号:
    14360189
  • 财政年份:
    2002
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms controlling pancreatic β cell regeneration and pathophysiological significance of pancreatic nestin-expressing cells
控制胰腺β细胞再生的分子机制及胰腺巢蛋白表达细胞的病理生理意义
  • 批准号:
    14571063
  • 财政年份:
    2002
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SFB 542: Molecular Mechanisms of Cytokine-Mediated Inflammatory Processes: Signal Transduction and Pathophysiological Consequences
SFB 542:细胞因子介导的炎症过程的分子机制:信号转导和病理生理学后果
  • 批准号:
    5483639
  • 财政年份:
    1999
  • 资助金额:
    $ 315.4万
  • 项目类别:
    Collaborative Research Centres
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了